Supplemental material
Open access
1,849
Views
6
CrossRef citations to date
0
Altmetric
Research Paper
Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules
Marco Costantinia GSK, Siena, ItalyCorrespondence[email protected]
View further author information
, View further author information
Andrea Callegarob GSK, Rixensart, BelgiumView further author information
, Jiří Beranc Vaccination and Travel Medicine Centre, Hradec Králové, Czechia;d Department for Tropical, Travel Medicine and Immunization, Institute for Postgraduate Medical Education in Prague, Prague 10, CzechiaView further author information
, Valérie Berlaimonte GSK, Wavre, Belgiumhttps://orcid.org/0000-0003-3850-4477View further author information
& Ilaria Galgania GSK, Siena, ItalyView further author information
Pages 2274-2279
|
Received 19 Sep 2019, Accepted 28 Nov 2019, Published online: 17 Jan 2020
Related Research Data
Chapter 25 – Tick-borne encephalitis
Source:
Elsevier
Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedules
Source:
Informa UK Limited
Report of the 19th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE) - TBE in a changing world.
Source:
Elsevier BV
Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine.
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.